<p>人寿保险公司（NYSE:HUM - 获取免费报告）在周三发布的报告中，摩根士丹利将其目标价从 277.00 美元下调至 262.00 美元，MarketScreener 报道。该公司目前对这家保险提供商的股票给予 “持平” 评级。摩根士丹利的目标价表明，相较于公司当前价格，存在 1.62% 的潜在上涨空间。</p>
<ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
<p>其他几位分析师也对该股票发布了报告。KeyCorp 在周五的报告中重申了对人寿保险公司股票的 “行业权重” 评级。Truist Financial 在 11 月 10 日的研究报告中将人寿保险公司的目标价从 300.00 美元下调至 285.00 美元，并对该股票给予 “持有” 评级。美国银行在 10 月 10 日的研究报告中将人寿保险公司的目标价从 280.00 美元上调至 300.00 美元，并给予该公司 “中性” 评级。高盛集团在 11 月 24 日的报告中将人寿保险公司的目标价从 235.00 美元下调至 215.00 美元，并对该股票给予 “卖出” 评级。最后，富国银行在 10 月 7 日的研究报告中将人寿保险公司的目标价从 344.00 美元上调至 347.00 美元，并给予该公司 “增持” 评级。九位研究分析师对该股票给予 “买入” 评级，十位给予 “持有” 评级，两位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 294.32 美元。</p>
<p><strong>查看我们最新的人寿保险公司股票分析</strong></p>
<h2>人寿保险公司价格表现</h2>
<ul>
<li>2 只不受关税影响的医疗保健抗衰退股票</li>
</ul>
<p>人寿保险公司股票在周三开盘价为 257.83 美元。人寿保险公司的 52 周低点为 206.87 美元，52 周高点为 315.35 美元。该公司的 50 日移动平均价格为 261.24 美元，200 日移动平均价格为 259.00 美元。该公司的债务与股本比率为 0.68，速动比率为 2.02，流动比率为 2.02。该股票的市值为 310.1 亿美元，市盈率为 24.14，市盈增长比率为 1.61，贝塔值为 0.46。</p>
<p>人寿保险公司（NYSE:HUM - 获取免费报告）在 11 月 5 日发布了季度财报。该保险提供商报告的每股收益为 3.24 美元，超出分析师共识预期的 2.95 美元，超出幅度为 0.29 美元。该公司在本季度的收入为 326.5 亿美元，而分析师预期为 319.9 亿美元。人寿保险公司的股本回报率为 12.86%，净利润率为 1.02%。该公司的收入较去年同期增长了 11.1%。在去年同期，该公司每股收益为 4.16 美元。股票分析师预测人寿保险公司在当前财政年度的每股收益将达到 16.47 美元。</p>
<h2>机构投资者对人寿保险公司的看法</h2>
<ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
<p>一些大型投资者最近增加或减少了对人寿保险公司的持股。Elevation Point Wealth Partners LLC 在第二季度购买了人寿保险公司的新股份，价值约为 32,000 美元。Mather Group LLC 在第三季度购买了人寿保险公司的新股份，价值约为 34,000 美元。AlphaCore Capital LLC 在第二季度收购了人寿保险公司的新股份，价值约为 39,000 美元。私人财富管理集团在第三季度将其在人人寿保险公司的持股增加了 47.5%。私人财富管理集团现在拥有 149 股人寿保险公司的股票，价值 39,000 美元，此前在上个季度又购买了 48 股。最后，Larson Financial Group LLC 在第三季度将其在人人寿保险公司的持股增加了 114.1%。Larson Financial Group LLC 现在拥有 152 股人寿保险公司的股票，价值 40,000 美元，此前在上个季度又购买了 81 股。92.38% 的股票由机构投资者和对冲基金持有。</p>
<h2>人寿保险公司简介</h2>
<p>（获取免费报告）</p>
<p>人寿保险公司及其子公司在美国提供医疗和专业保险产品。它通过保险和 CenterWell 两个部门运营。该公司向个人提供医疗和补充福利计划。它与医疗保险和医疗补助服务中心签订合同，管理有限收入新合格过渡处方药计划；并与各州签订合同，提供医疗补助、双重合格和长期支持服务福利。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过人寿保险公司</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>3 只下跌超过 60% 的科技股——哪一只值得购买？</li>
<li>3 只值得考虑的股息之王</li>
<li>25 年后，思科终于从互联网泡沫崩溃中恢复</li>
<li>3 只沃伦·巴菲特现在值得购买的股票</li>
<li>AI 芯片离不开这两家被低估的科技巨头</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhVTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhVTQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在人人寿保险公司吗？</h2>
<p>在你考虑人寿保险公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而人寿保险公司并不在名单上。</p>
<p>虽然人寿保险公司目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

休曼纳

<p>摩根士丹利已将对休曼纳的目标股价从 277.00 美元下调至 262.00 美元，并给予 “持平” 评级。其他分析师也调整了对休曼纳的评级和目标股价。该股周三开盘价为 257.83 美元，52 周区间为 206.87 美元至 315.35 美元。休曼纳报告了强劲的季度收益，营收同比增长 11.1%。机构投资者也在调整对该公司的持股</p>

<p>Humana (NYSE:HUM - Get Free Report) had its price target lowered by stock analysts at Morgan Stanley from $277.00 to $262.00 in a report released on Wednesday,MarketScreener reports. The firm presently has an &#34;equal weight&#34; rating on the insurance provider's stock. Morgan Stanley's price objective indicates a potential upside of 1.62% from the company's current price.</p>
<div class="lb-trans"><p>人寿保险公司（NYSE:HUM - 获取免费报告）在周三发布的报告中，摩根士丹利将其目标价从 277.00 美元下调至 262.00 美元，MarketScreener 报道。该公司目前对这家保险提供商的股票给予 “持平” 评级。摩根士丹利的目标价表明，相较于公司当前价格，存在 1.62% 的潜在上涨空间。</p>
</div><ul>
<li>UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels</li>
</ul>
<div class="lb-trans"><ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
</div><p>Several other analysts have also issued reports on the stock. KeyCorp restated a &#34;sector weight&#34; rating on shares of Humana in a report on Friday. Truist Financial dropped their price target on Humana from $300.00 to $285.00 and set a &#34;hold&#34; rating on the stock in a research note on Monday, November 10th. Bank of America lifted their target price on Humana from $280.00 to $300.00 and gave the company a &#34;neutral&#34; rating in a research note on Friday, October 10th. The Goldman Sachs Group lowered their price objective on Humana from $235.00 to $215.00 and set a &#34;sell&#34; rating on the stock in a report on Monday, November 24th. Finally, Wells Fargo &amp; Company lifted their price target on shares of Humana from $344.00 to $347.00 and gave the company an &#34;overweight&#34; rating in a research report on Tuesday, October 7th. Nine research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and a consensus target price of $294.32.</p>
<div class="lb-trans"><p>其他几位分析师也对该股票发布了报告。KeyCorp 在周五的报告中重申了对人寿保险公司股票的 “行业权重” 评级。Truist Financial 在 11 月 10 日的研究报告中将人寿保险公司的目标价从 300.00 美元下调至 285.00 美元，并对该股票给予 “持有” 评级。美国银行在 10 月 10 日的研究报告中将人寿保险公司的目标价从 280.00 美元上调至 300.00 美元，并给予该公司 “中性” 评级。高盛集团在 11 月 24 日的报告中将人寿保险公司的目标价从 235.00 美元下调至 215.00 美元，并对该股票给予 “卖出” 评级。最后，富国银行在 10 月 7 日的研究报告中将人寿保险公司的目标价从 344.00 美元上调至 347.00 美元，并给予该公司 “增持” 评级。九位研究分析师对该股票给予 “买入” 评级，十位给予 “持有” 评级，两位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 294.32 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on HUM</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的人寿保险公司股票分析</strong></p>
</div><h2>Humana Price Performance</h2>
<div class="lb-trans"><h2>人寿保险公司价格表现</h2>
</div><ul>
<li>2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只不受关税影响的医疗保健抗衰退股票</li>
</ul>
</div><p>Shares of HUM opened at $257.83 on Wednesday. Humana has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The company has a 50 day moving average price of $261.24 and a 200-day moving average price of $259.00. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The stock has a market capitalization of $31.01 billion, a PE ratio of 24.14, a PEG ratio of 1.61 and a beta of 0.46.</p>
<div class="lb-trans"><p>人寿保险公司股票在周三开盘价为 257.83 美元。人寿保险公司的 52 周低点为 206.87 美元，52 周高点为 315.35 美元。该公司的 50 日移动平均价格为 261.24 美元，200 日移动平均价格为 259.00 美元。该公司的债务与股本比率为 0.68，速动比率为 2.02，流动比率为 2.02。该股票的市值为 310.1 亿美元，市盈率为 24.14，市盈增长比率为 1.61，贝塔值为 0.46。</p>
</div><p>Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts' consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analysts' expectations of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm's revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.16 EPS. Equities analysts predict that Humana will post 16.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>人寿保险公司（NYSE:HUM - 获取免费报告）在 11 月 5 日发布了季度财报。该保险提供商报告的每股收益为 3.24 美元，超出分析师共识预期的 2.95 美元，超出幅度为 0.29 美元。该公司在本季度的收入为 326.5 亿美元，而分析师预期为 319.9 亿美元。人寿保险公司的股本回报率为 12.86%，净利润率为 1.02%。该公司的收入较去年同期增长了 11.1%。在去年同期，该公司每股收益为 4.16 美元。股票分析师预测人寿保险公司在当前财政年度的每股收益将达到 16.47 美元。</p>
</div><h2>Institutional Investors Weigh In On Humana</h2>
<div class="lb-trans"><h2>机构投资者对人寿保险公司的看法</h2>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
</div><p>A number of large investors have recently added to or reduced their stakes in HUM. Elevation Point Wealth Partners LLC purchased a new position in shares of Humana during the 2nd quarter valued at approximately $32,000. Mather Group LLC. bought a new stake in shares of Humana in the 3rd quarter worth about $34,000. AlphaCore Capital LLC acquired a new stake in shares of Humana in the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC lifted its position in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock worth $39,000 after purchasing an additional 48 shares during the last quarter. Finally, Larson Financial Group LLC increased its holdings in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock valued at $40,000 after buying an additional 81 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些大型投资者最近增加或减少了对人寿保险公司的持股。Elevation Point Wealth Partners LLC 在第二季度购买了人寿保险公司的新股份，价值约为 32,000 美元。Mather Group LLC 在第三季度购买了人寿保险公司的新股份，价值约为 34,000 美元。AlphaCore Capital LLC 在第二季度收购了人寿保险公司的新股份，价值约为 39,000 美元。私人财富管理集团在第三季度将其在人人寿保险公司的持股增加了 47.5%。私人财富管理集团现在拥有 149 股人寿保险公司的股票，价值 39,000 美元，此前在上个季度又购买了 48 股。最后，Larson Financial Group LLC 在第三季度将其在人人寿保险公司的持股增加了 114.1%。Larson Financial Group LLC 现在拥有 152 股人寿保险公司的股票，价值 40,000 美元，此前在上个季度又购买了 81 股。92.38% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Humana Company Profile</h2>
<div class="lb-trans"><h2>人寿保险公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.</p>
<div class="lb-trans"><p>人寿保险公司及其子公司在美国提供医疗和专业保险产品。它通过保险和 CenterWell 两个部门运营。该公司向个人提供医疗和补充福利计划。它与医疗保险和医疗补助服务中心签订合同，管理有限收入新合格过渡处方药计划；并与各州签订合同，提供医疗补助、双重合格和长期支持服务福利。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Humana</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li>
<li>3 Dividend Kings To Consider</li>
<li>25 Years Later, Cisco Finally Recovers From the Dot-Com Crash</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>AI Chips Can’t Exist Without These 2 Underrated Tech Giants</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过人寿保险公司</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>3 只下跌超过 60% 的科技股——哪一只值得购买？</li>
<li>3 只值得考虑的股息之王</li>
<li>25 年后，思科终于从互联网泡沫崩溃中恢复</li>
<li>3 只沃伦·巴菲特现在值得购买的股票</li>
<li>AI 芯片离不开这两家被低估的科技巨头</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhVTQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=HUM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Humana Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在人人寿保险公司吗？</h2>
</div><p>Before you consider Humana, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑人寿保险公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而人寿保险公司并不在名单上。</p>
</div><p>While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然人寿保险公司目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

摩根士丹利已降低了对休曼纳（NYSE:HUM）股票价格的预期